CANbridge Pharmaceuticals Inc. (Stock Code: 1228) will convene an Extraordinary General Meeting (EGM) on December 4, 2025, at 9:00 a.m., to be conducted virtually. Shareholders are invited to vote on proposals including the granting of a new general mandate to the board of directors to allot and issue shares, subject to a maximum of 20% of the company’s issued share capital as at the date of the EGM (excluding any treasury shares).

Another resolution will address extending this new mandate to shares repurchased by the company, as authorized under the repurchase mandate approved at the annual general meeting on June 27, 2025. The notice of EGM is detailed in the circular dated November 19, 2025. Shareholders should submit completed proxy forms to the Hong Kong branch share registrar at least 48 hours before the meeting. Attendance and voting instructions, including online participation, are specified in the relevant documentation provided by the company.